search

Kathleen Wilson

Senior Manager, Health Economics and Outcomes Research

Kathleen Wilson headshot - woman with long dark hair smiling for headshot in a dark blazer

Kathleen Wilson supports the design and execution of observational research studies that generate real-world evidence (RWE) for pharmaceutical and other life sciences companies.

Kathleen has extensive expertise in observational study design, statistical methodology, and the use of real-world data sources, including administrative claims, electronic health records, and patient and disease registries.

With more than 15 years of experience in HEOR and health services research, Kathleen previously served as a Senior Manager at IBM Watson Health, where she led and supported the execution of health economics, health outcomes, and epidemiological studies for life sciences clients.

Kathleen has co-authored numerous conference abstracts and more than 50 manuscripts published in peer-reviewed journals across a range of therapeutic areas, including oncology, rheumatology, respiratory diseases, and rare diseases.

Kathleen holds a Master of Public Health from Dartmouth College and a Bachelor of Science in Applied Mathematics from the University of Washington.

Authored Content
Placeholder
Real-world evidence, respiratory

Healthcare Resource Utilization and Economic Burden Among Patients With COPD Following Cardiopulmonary Events: Evidence From the ABACOS OUTCOMES Study

Accepted for presentation at American Thoracic Society International Conference. Findings available upon request. Contact us for more information.

Placeholder
Respiratory

Chronic Obstructive Pulmonary Disease (COPD) Exacerbations Before and After Completion of Specialist Visits: Results from the DUALITY Specialist

Accepted for presentation at American Thoracic Society International Conference. Findings available upon request. Contact us for more information.

Placeholder
Neurology, real-world evidence

Real-World Treatment Patterns, Discontinuation, and Treatment Switches in Patients With Generalized Myasthenia Gravis (gMG): A Retrospective Claims Analysis

Accepted for presentation at American Academy of Neurology. Findings available upon request. Contact us for more information.

Placeholder
Cardiovascular

Predictors of Timely Hypertension Treatment Escalation in the United States: Results from the Real-World BREAKTHROUGH Patient Registry

Accepted for presentation at American College of Cardiology (ACC.26). Findings available upon request. Contact us for more information.

Share